US Egg Allergy Market Research Report Information by Age Group (Children and Adults), Diagnosis & Treatment (Diagnosis [Skin Test, Blood Test, Food Challenge and others] and Treatment [Medication and Oral Immunotherapy]), End User (Hospitals and Clinics, Diagnostic Centers, Research Institutes and others) - Forecast till 2030

The Egg Allergy Market in North America is a significant segment of the global market, driven by the high prevalence of egg allergies in the region. North America has witnessed a rise in the number of individuals suffering from food allergies, including egg allergies, which has led to an increased demand for diagnostic tests and treatment options.

According to the Food Allergy Research and Education (FARE), approximately 6% of children and 3-4% of adults in the United States have a diagnosed food allergy. Among these food allergies, egg allergy is one of the most common, especially in children. The Centers for Disease Control and Prevention (CDC) estimates that around 2% of children in the U.S. are affected by egg allergy.

The increasing awareness of food allergies and their potential consequences has resulted in a growing demand for accurate and efficient diagnostic methods in North America. Various diagnostic tests, including skin prick tests and blood tests, are commonly used to confirm egg allergies. These tests help healthcare professionals identify the presence of specific antibodies that indicate an allergic reaction to egg proteins.

In addition to diagnostic tests, the market for egg allergy treatment options in North America is also expanding. The primary focus of treatment is the avoidance of egg and egg-containing products. However, in cases of accidental exposure or severe allergies, emergency medications such as epinephrine auto-injectors (EpiPens) are prescribed to manage potential allergic reactions, including anaphylaxis.

Pharmaceutical companies and healthcare institutions in North America are actively engaged in research and development activities to improve diagnostic methods and treatment options. They are working on innovative technologies, including oral immunotherapy, which aims to desensitize individuals with egg allergies and reduce the severity of their reactions.

Overall, the Egg Allergy Market in North America is driven by the high prevalence of egg allergies and the increasing awareness of food allergies in the region. The market is witnessing steady growth, with a focus on advanced diagnostic methods and effective treatment options. The ongoing research and development activities are expected to further enhance the market by introducing innovative solutions to address the challenges associated with egg allergies.